{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:49:18Z","timestamp":1788306558907,"version":"build-2803163510"},"reference-count":47,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Diabetes"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1111\/pedi.12384","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T19:58:32Z","timestamp":1459454312000},"page":"277-282","source":"Crossref","is-referenced-by-count":11,"title":["Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus"],"prefix":"10.1155","volume":"18","author":[{"given":"Dionisios","family":"Chrysis","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Medical School; University of Patras; Patra Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Efthymiadou","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Medical School; University of Patras; Patra Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Mermigka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical School; University of Patras; Patra Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Kritikou","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical School; University of Patras; Patra Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bessie E","family":"Spiliotis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Medical School; University of Patras; Patra Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"10.1111\/pedi.12384-BIB0001|pedi12384-cit-0001","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2337\/dc10-0505","article-title":"Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study","volume":"33","author":"Margeirsdottir","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12384-BIB0002|pedi12384-cit-0002","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00125-005-1832-1","article-title":"Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?","volume":"48","author":"Dahl-Jorgensen","year":"2005","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12384-BIB0003|pedi12384-cit-0003","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/01.ATV.15.12.2222","article-title":"Relation of a postmortem renal index of hypertension to atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"15","author":"McGill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/pedi.12384-BIB0004|pedi12384-cit-0004","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00125-007-0921-8","article-title":"High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study","volume":"51","author":"Margeirsdottir","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12384-BIB0005|pedi12384-cit-0005","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12384-BIB0006|pedi12384-cit-0006","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00125-005-0082-6","article-title":"Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway","volume":"49","author":"Skrivarhaug","year":"2006","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12384-BIB0007|pedi12384-cit-0007","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1586\/14779072.4.6.801","article-title":"The osteoprotegerin\/RANK\/RANKL system: a bone key to vascular disease","volume":"4","author":"Kiechl","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1111\/pedi.12384-BIB0008|pedi12384-cit-0008","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/pedi.12384-BIB0009|pedi12384-cit-0009","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/pedi.12384-BIB0010|pedi12384-cit-0010","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1111\/pedi.12384-BIB0011|pedi12384-cit-0011","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/ATVBAHA.109.184101","article-title":"Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003","volume":"29","author":"Semb","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/pedi.12384-BIB0012|pedi12384-cit-0012","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/pedi.12384-BIB0013|pedi12384-cit-0013","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/eje.1.02049","article-title":"Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients","volume":"154","author":"Rasmussen","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/pedi.12384-BIB0014|pedi12384-cit-0014","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1007\/s00125-008-1123-8","article-title":"Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy","volume":"51","author":"Jorsal","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12384-BIB0015|pedi12384-cit-0015","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00592-009-0146-z","article-title":"Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus","volume":"47","author":"Singh","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1111\/pedi.12384-BIB0016|pedi12384-cit-0016","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/00365511003653599","article-title":"Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?","volume":"70","author":"Grauslund","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/pedi.12384-BIB0017|pedi12384-cit-0017","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.diabres.2006.09.008","article-title":"Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients","volume":"76","author":"Xiang","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/pedi.12384-BIB0018|pedi12384-cit-0018","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/eje.1.02052","article-title":"Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status","volume":"153","author":"Galluzzi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/pedi.12384-BIB0019|pedi12384-cit-0019","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1155\/2013\/102120","article-title":"Osteoprotegerin, soluble receptor activator of nuclear factor- kappa B ligand, and subclinical atherosclerosis in children and adolescents with type 1 diabetes mellitus","volume":"2013","author":"Lambrinoudaki","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1111\/pedi.12384-BIB0020|pedi12384-cit-0020","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/pedi.12384-BIB0021|pedi12384-cit-0021","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/pedi.12384-BIB0022|pedi12384-cit-0022","doi-asserted-by":"publisher","first-page":"493.e1","DOI":"10.1016\/j.ahj.2006.06.005","article-title":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study","volume":"152","author":"Schulze","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/pedi.12384-BIB0023|pedi12384-cit-0023","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1111\/pedi.12384-BIB0024|pedi12384-cit-0024","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","article-title":"Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg","volume":"28","author":"Leong","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/pedi.12384-BIB0025|pedi12384-cit-0025","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1210\/jc.2006-2643","article-title":"Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations","volume":"92","author":"Altinova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/pedi.12384-BIB0026|pedi12384-cit-0026","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2337\/dc07-1762","article-title":"Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"31","author":"Lajer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12384-BIB0027|pedi12384-cit-0027","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jpeds.2010.09.058","article-title":"Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children","volume":"158","author":"Huemer","year":"2011","journal-title":"J Pediatr"},{"key":"10.1111\/pedi.12384-BIB0028|pedi12384-cit-0028","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diabres.2009.09.019","article-title":"Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite\/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus","volume":"86","author":"Pitocco","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/pedi.12384-BIB0029|pedi12384-cit-0029","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1475-2840-8-27","article-title":"A study of endothelial function and circulating asymmetric dimethylarginine levels in people with type 1 diabetes without macrovascular disease or microalbuminuria","volume":"8","author":"Sibal","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1111\/pedi.12384-BIB0030|pedi12384-cit-0030","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/00365510802419454","article-title":"Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes","volume":"69","author":"Heilman","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/pedi.12384-BIB0031|pedi12384-cit-0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.33549\/physiolres.931418","article-title":"Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1","volume":"58","author":"Jehlicka","year":"2009","journal-title":"Physiol Res"},{"key":"10.1111\/pedi.12384-BIB0032|pedi12384-cit-0032","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/187221411799015372","article-title":"Fetuin-A: a multifunctional protein","volume":"5","author":"Mori","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1111\/pedi.12384-BIB0033|pedi12384-cit-0033","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/j.2042-7158.2012.01561.x","article-title":"Role of fetuin-A in atherosclerosis associated with diabetic patients","volume":"64","author":"Singh","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/pedi.12384-BIB0034|pedi12384-cit-0034","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5507\/bp.2015.018","article-title":"Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature","volume":"159","author":"Dabrowska","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1111\/pedi.12384-BIB0035|pedi12384-cit-0035","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2337\/dc10-0788","article-title":"Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease","volume":"34","author":"Lorant","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12384-BIB0036|pedi12384-cit-0036","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay","volume":"42","author":"Schulze","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/pedi.12384-BIB0037|pedi12384-cit-0037","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/01.CIR.0000124725.46165.2C","article-title":"Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes","volume":"109","author":"Jarvisalo","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/pedi.12384-BIB0038|pedi12384-cit-0038","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/pedi.12384-BIB0039|pedi12384-cit-0039","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.2337\/dc07-0992","article-title":"Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients","volume":"30","author":"Avignon","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12384-BIB0040|pedi12384-cit-0040","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.2337\/diacare.26.10.2923","article-title":"Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control","volume":"26","author":"Snell-Bergeon","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12384-BIB0041|pedi12384-cit-0041","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1600-051X.2009.01440.x","article-title":"Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus","volume":"36","author":"Lappin","year":"2009","journal-title":"J Clin Periodontol"},{"key":"10.1111\/pedi.12384-BIB0042|pedi12384-cit-0042","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.2353\/ajpath.2006.060398","article-title":"An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction","volume":"169","author":"Secchiero","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/pedi.12384-BIB0043|pedi12384-cit-0043","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bone.2010.09.034","article-title":"Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass","volume":"48","author":"Dimitri","year":"2011","journal-title":"Bone"},{"key":"10.1111\/pedi.12384-BIB0044|pedi12384-cit-0044","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/jpem-2014-0083","article-title":"Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin","volume":"28","author":"Krebs","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/pedi.12384-BIB0045|pedi12384-cit-0045","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/CS20080079","article-title":"Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with type 1 diabetes","volume":"115","author":"Marcovecchio","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/pedi.12384-BIB0046|pedi12384-cit-0046","first-page":"287","article-title":"Evaluation of fetuin-A and carotid intima-media thickness in adolescent type 1 diabetic patients","volume":"28","author":"Abd El Dayem","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/pedi.12384-BIB0047|pedi12384-cit-0047","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1203\/PDR.0b013e3181bc3f60","article-title":"The physiologic development of fetuin-a serum concentrations in children","volume":"66","author":"Hausler","year":"2009","journal-title":"Pediatr Res"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpedi.12384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpedi.12384","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/pedi.12384\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:09:11Z","timestamp":1671818951000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pedi.12384"}},"subtitle":["OPG, ADMA, and Fetuin-A in T1DM"],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1111\/pedi.12384","archive":["Portico"],"relation":{},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}